Repurchase of shares in Millicom
September 17, 2021 17:00 ET
|
Millicom International Cellular S.A.
Repurchase of shares in Millicom Luxembourg, September 17, 2021 - During the period September 9, 2021 – September 15, 2021, Millicom repurchased a total of 131,559 of its Swedish Depository...
Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 17, 2021 16:52 ET
|
Ocugen
MALVERN, Pa., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness...
Organovo Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum
September 17, 2021 16:10 ET
|
Organovo, Inc.
SOLANA BEACH, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that the Company’s annual meeting of shareholders, on September 14, 2021, at 9:00...
Pasithea Therapeutics Corp. Announces Closing of $24.0 Million Initial Public Offering
September 17, 2021 16:05 ET
|
Pasithea
MIAMI BEACH, Fla., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new...
Grindrod Shipping Holdings Ltd. Announces Closing of IVS Bulk Financing and IVS Phoenix Acquisition
September 17, 2021 16:05 ET
|
Grindrod Shipping Holdings Ltd.
SINGAPORE, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Grindrod Shipping Holdings Ltd. (NASDAQ: GRIN) (JSE: GSH) (“Grindrod Shipping” or "Company" or “it” or “we”), a global provider of maritime...
Protara Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 17, 2021 16:05 ET
|
Protara Therapeutics
NEW YORK, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases...
Century Therapeutics Announces Its Addition to the Russell 2000® Index
September 17, 2021 16:01 ET
|
Century Therapeutics, Inc.
PHILADELPHIA, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in...
Wintrust Financial Corporation Announces Third Quarter and Year-to-Date 2021 Earnings Release Schedule
September 17, 2021 16:01 ET
|
Wintrust Financial Corporation
ROSEMONT, Ill., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Wintrust Financial Corporation ("Wintrust") (Nasdaq: WTFC) today announced it will release its third quarter and year-to-date 2021 earnings results...
Passage Bio Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
September 17, 2021 16:01 ET
|
Passage Bio
PHILADELPHIA, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous...
Nuwellis, Inc. Announces Closing of $10.0 Million Underwritten Public Offering of Common Stock Including Full Exercise of Over-Allotment Option
September 17, 2021 16:00 ET
|
Nuwellis, Inc.
EDEN PRAIRIE, Minn., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) (the “Company”) announced today the closing of its previously announced underwritten public offering of 4,005,588...